Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04274491 · ClinicalTrials.gov registry record

Predictors of Recovery Expectancy

A clinical trial of Surgery and Pelvic Organ Prolapse, sponsored by Indiana University.

Completed
Registry status
202
Enrollment target
1
Study location

NCT04274491: Completed study of Surgery and Pelvic Organ Prolapse, sponsored by Indiana University.

NCT04274491 is a study of Surgery and Pelvic Organ Prolapse that has completed, run by Indiana University. The registered enrollment target is 202 participants, below the 52,850-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04274491, a study of Surgery and Pelvic Organ Prolapse, has completed, sponsored by Indiana University.

COMPLETED
Registry status
202 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to identify factors that influence a person's expectations regarding recovery from pelvic organ prolapse surgery. This is important because a person's expectations regarding recovery from surgery help to predict how a person will actually recover. Our hypothesis is that women with multiple roles will have expectations of a longer surgical recovery time after surgery for pelvic organ prolapse after controlling for known predictors of recovery expectancies. Participants will complete a preoperative online survey. Additional online surveys will be send on postoperative days 14 and 42 to measure postdischarge surgical recovery.

Primary Outcome

Expectation that recovery from surgery will be greater than 6 weeks from 0 to 100 percent where 100% indicates complete recovery within 6 weeks

Study Locations (1)

Indiana

  • Indiana University Urogynecology - Indianapolis

Trial Details

FieldValue
Enrollment Target 202 participants
Start Date 2020-03-01
Est. Completion 2022-02-01
Indiana University

890 total trials

What the finished NCT04274491 record still lists

NCT04274491 is an observational study that tracks outcomes without assigning an intervention. The registered 202 participants enrollment target is mid-sized for trials with a published cap, below the 52,850-participant average among 120 other Surgery trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Surgery appearing as the primary indexed condition, and to 0 interventions.

NCT04274491 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT04274491 about?

NCT04274491 is a clinical study titled "Predictors of Recovery Expectancy". The purpose of this study is to identify factors that influence a person's expectations regarding recovery from pelvic organ prolapse surgery. This is important because a person's expectations regarding recovery from surgery help to predict how a person will actually recover. Our hypothesis is that ...

What is the current status of trial NCT04274491?

This trial is currently completed. The enrollment target is 202 participants. The study started on 2020-03-01. Estimated completion is 2022-02-01.

What conditions does trial NCT04274491 study?

This clinical trial studies the following conditions: Surgery, Pelvic Organ Prolapse.

Who is sponsoring clinical trial NCT04274491?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04274491 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04274491's enrollment target sits among peer trials

202 39th of 120 higher than 81 of 120 other Surgery trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05272254 · 202 participants · Phase 2

    Povidone Iodine Efficacy Study

  • NCT05701280 · 202 participants · NA

    Pilot/Pivotal Study of DBS+Rehab After Stroke

  • NCT05932589 · 202 participants

    Neurophysiologic Biomarkers in Rett Syndrome

  • NCT06014931 · 202 participants · NA

    Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04274491, the US trial registry maintained by the National Library of Medicine. NCT04274491 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.